Fulcrum Therapeutics FULC
NASDAQ FULC
$3.69 -0.01 (-0.27%)
As of: Sep 30, 2026 · 3:59 PM EDT

Fulcrum Therapeutics (FULC) EV to CFO (2025)

Updated

Fulcrum Therapeutics' (FULC) EV to CFO came in at 14.51 for Q1 2025.

Analysis

Fulcrum Therapeutics (FULC) EV to CFO (2025) Analysis & Trends

For the trailing twelve months through Mar 31, 2025, EV to CFO at Fulcrum Therapeutics was -13.35.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Fulcrum Therapeutics 282.26 Mn 282.26 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 14.51
API Access

Fulcrum Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=FULC&period=max&api_key=YOUR_API_KEY